ABCC1 and diffuse large B-cell lymphoma: A significant high expression of MRP1/ABCC1 was detected at initial diagnosis in the Refractory and Relapsed DLBCL groups (70.33% ± 12.18, p = 0.002, and 56.86% ± 11.29, p = 0.03 vs. Remission, respectively).